Nomura Asset Management Co. Ltd. reduced its position in Cigna Corporation (NYSE:CI) by 7.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 86,334 shares of the health services provider’s stock after selling 6,452 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Cigna were worth $16,139,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Capstone Investment Advisors Netherlands B.V. purchased a new stake in Cigna in the 2nd quarter worth about $106,000. Saratoga Research & Investment Management purchased a new stake in Cigna in the 3rd quarter worth about $112,000. Horan Capital Advisors LLC. purchased a new position in shares of Cigna during the third quarter worth approximately $123,000. Parallel Advisors LLC increased its position in shares of Cigna by 62.3% during the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after acquiring an additional 307 shares during the period. Finally, Acrospire Investment Management LLC increased its position in shares of Cigna by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock worth $167,000 after acquiring an additional 400 shares during the period. 87.85% of the stock is currently owned by institutional investors.

A number of brokerages have recently commented on CI. Citigroup raised their target price on shares of Cigna from $198.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Morgan Stanley raised their target price on shares of Cigna from $195.00 to $223.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. Jefferies Group raised their target price on shares of Cigna from $221.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $220.00 target price (up from $185.00) on shares of Cigna in a research report on Friday, November 3rd. Finally, Zacks Investment Research lowered shares of Cigna from a “buy” rating to a “hold” rating in a research report on Friday, November 10th. Three investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $201.50.

In other Cigna news, CAO Mary T. Hoeltzel sold 575 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $197.03, for a total value of $113,292.25. Following the completion of the sale, the chief accounting officer now directly owns 2,499 shares in the company, valued at $492,377.97. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the firm’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The disclosure for this sale can be found here. Over the last three months, insiders have sold 36,203 shares of company stock worth $7,211,251. 1.30% of the stock is currently owned by corporate insiders.

Cigna Corporation (CI) opened at $203.06 on Wednesday. The stock has a market cap of $50,323.26, a P/E ratio of 19.66, a P/E/G ratio of 1.56 and a beta of 0.50. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39. Cigna Corporation has a 1-year low of $131.03 and a 1-year high of $212.46.

Cigna (NYSE:CI) last issued its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.36 by $0.47. The company had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. Cigna had a net margin of 5.74% and a return on equity of 18.85%. Cigna’s revenue was up 5.1% compared to the same quarter last year. During the same period last year, the company posted $1.94 earnings per share. equities analysts predict that Cigna Corporation will post 10.34 EPS for the current year.

TRADEMARK VIOLATION WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/12/06/cigna-corporation-ci-position-trimmed-by-nomura-asset-management-co-ltd.html.

About Cigna

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.